Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it’s accuracy, cost effectiveness and the publication of national guidelines advocating its use. Spirometry is a common test that allows physicians to…
In the Issue of the New England Journal of Medicine an investigation of the role of financial incentives and nudges in promoting smoking cessation, with particular emphasis on the importance of loss aversion and pre-commitment is explored. In the past 40 years, we have seen a revolution in thinking about thinking. The central idea is…
MD Spiro prides itself on not only offering incredible spirometry products for your practice, but also prides itself on providing articles and industry updates for our customers. Below is a new study showing you trends, R&D progress, and predicted revenues in Asthma and COPD Therapies. So where’s the asthma and COPD therapies market heading? Visiongain’s…
Today, is Earth Day. A statement released by the White House outlines an initiative to combat the health-related effects of climate change, with an emphasis on chronic obstructive pulmonary disease (COPD) and asthma. “The Centers for Disease Control and Prevention (CDC) is releasing an Adaptation in Action Report highlighting successful actions state and local…
Diabetics now have a new option thanks to the breakthrough new medication AFREZZA®, an inhaled insulin now available by prescription. The labeling for AFREZZA®, mandates spirometry testing (specifically FEV1) to rule out chronic lung disease prior to initiating therapy, six months after initiation and every year thereafter1. MD Spiro offers a number of spirometer options…
Reducing the risks of e-cigarettes to smokers, encouraging the smoking-cessation potential, and restricting access by nonsmokers offer a regulatory trifecta that can be implemented immediately, according to a former FDA official. The “roadmap” to effective regulation hinges on implementation of the pending FDA deeming rule, which is expected to go into effect later this year….
The link between smoking and cancer is well known, but there’s another major killer associated with smoking that often goes unnoticed – heart disease. “Smoking not only causes cancer. Smoking is also a significant contributor to heart disease, the top cause of death for men and women in the U.S.,” said Paul Fitzpatrick, manager of…
The draft guideline – NICE’s first on asthma – reinforces recommendations made in the 2014 BTS/SIGN asthma guideline, which also supports spirometry as the preferred initial test to assess the presence and severity of airflow obstruction. A number of methods and assessments are available to determine the likelihood of asthma. These include measures of airflow…